Abstract
During the past several years, remarkable progress has been made in understanding the nitric oxide-guanylate cyclase signal transduction system. Nitric oxide (NO) has undergone considerable clinical investigation for acute respiratory distress syndrome (ARDS) patients. This review concentrates on this area of clinical NO research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Zapol WM, Snider MT, Rie MA, Frikker M, Quinn DA (1985) Pulmonary circulation during adult respiratory distress syndrome. In: Zapol WM, Falke KJ (eds) Acute Respiratory Failure. Marcel Dekker, New York, pp 241–270
Radermacher P, Stanek B, Wust HJ, Tarnow J, Falke KJ (1990) Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: Effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anesthesiology 72: 238–244
Ignarro LJ, Buga GM, Wood KS, Byrns RE (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265–9269
Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524–526
Ignarro LJ (1991) Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 41: 485–490
Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109–142
Palmer RMJ, Ashton DS, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664–666
Ignarro LJ (1989) Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 65: 1–21
Gruetter CA, Gruetter DY, Lyon JE, Kadowitz PJ, Ignarro LJ (1981) Relationship between cyclic guanosine 3´,5´-monophosphate formation and relaxation of coronary artery arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide. J Pharmacol Exp Ther 219: 181–186
Dinh Xuan AT, Higenbottam TW, Clelland C, Pepke-Zaba, Wells FC, Wallwork J (1990) Acetylcholine and adenosine diphosphate cause endothelium-dependent relaxation of isolated human pulmonary arteries. Eur Respir J 3: 633–638
Gerlach H, Rossaint R, Pappert D, Knorr M, Falke KJ (1994) Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet 343: 518–519
Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J (1991) Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 338: 1173–1174
Frosteil CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM (1993) Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 78: 427–435
Högman M, Frostell C, Arnberg H, Hedenstierna G (1993) Inhalation of nitric oxide modulates methacholine-induced bronchoconstriction in the rabbit. Eur Respir J 6: 177–180
Cremona G, Dinh Xuan AT, Higenbottam TW (1991) Endothelium-derived relaxing factor and the pulmonary circulation. Lung 169: 185–202
Dinh Xuan AT, Higenbottam TW, Clelland C, Pepke-Zaba J, Cremona G, Wallwork J (1991) Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease. N Engl J Med 324: 1539–1547
Radomski MW, Palmer RMJ, Moncada S (1987) Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2: 1057–1058
Adatia I, Thompson J, Landzberg M, Wessel DL (1993) Inhaled nitric oxide in chronic obstructive lung disease. Lancet 341: 307–308
Frostell C, Fratacci M-D, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83: 2038–2047
Fratacci M-D, Frostell CG, Chen T-Y, Wain JC, Robinson DR, Zapol WM (1991) Inhaled nitric oxide: A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 75: 990–999
Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 328: 399–405
Bigatello LM, Hurford WE, Kacmarek RM (1994) Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Anesthesiology 80: 761–770
Puybasset L, Stewart TE, Rouby JJ, et al (1994) Inhaled nitric oxide reverses the increase in pulmonary vascular resistance induced by permissive hypercapnia in patients with acute respiratory distress syndrome. Anesthesiology 80: 1254–1267
Gerlach H, Pappert D, Lewandowski K, Rossaint R, Falke KJ (1993) Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 19: 443–449
Zapol WM (1993) Minidose inhaled nitric oxide: Less is better. Intensive Care Med 19: 433–434
Gerlach H, Rossaint R, Pappert D, Falke KJ (1993) Time course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 23: 449–502
Ricou B, Suter PM (1993) Variable effects of nitric oxide (NO) in ARDS patients. Am Rev Respir Dis 147: A350 (Abst)
Rich GF, Murphy GD, Ross CM, Johns RA (1993) Inhaled nitric oxide: A selective pulmonary vasodilator in cardiac surgical patients. Anesthesiology 78: 1028–1035
Grover R, Murdoch I, Smithies M, Mitchell I, Bihari D (1992) Nitric oxide during hand ventilation in a patient with acute respiratory failure. Lancet 340: 1038–1039
Dupuy PM, Shore SA, Drazen JM, Zapol WM (1992) Bronchodilator action of inhaled nitric oxide in guinea pigs. J Clin Invest 90: 421–428
Rengasamy A, Johns RA (1993) Regulation of nitric oxide synthase by nitric oxide. Mol Pharmacol 44: 124–128
Norman V, Keith CH (1965) Nitrogen oxides in tobacco smoke. Nature 205: 915–916
Centers for Disease Control (1988) Recommendations for occupational safety and health standard MMWR Morb Mortal Wkly Rep 37 (suppl S-7): 21
Foubert L, Fleming B, Latimer R, et al (1992) Safety guidelines for use of nitric oxide. Lancet 339: 1615–1616
Stavert DM, Lehert BE (1990) Nitric oxide and nitrogen dioxide as inducers of acute pulmonary injury when inhaled at relatively high concentrations for brief periods. Inhal Toxicol 2: 53–67
Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620–1624
Stamler JS, Singel DJ, Loscalzo J (1993) Biochemistry of nitric oxide and its redox-acti- vated forms. Science 258: 1898–1902
Beutler E (1977) Methemoglobinemia and sulfhemoglobinemia. In: Williams WJ, Beutler E, Erslev AJ, Rundles RW (eds) Hematology, 2nd edition. McGraw-Hill, New York, pp 491–494
Högman M, Frosteil C, Arnberg H, Hedenstierna G (1993) Bleeding time prolongation and NO inhalation. Lancet 341: 1664–1665
Högman M, Frosteil C, Arnberg H, Hedenstierna G (1993) Prolonged bleeding time during nitric oxide inhalation in the rabbit. Acta Physiol Scand 151: 125–129
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Zapol, W.M., Hurford, W.E. (1995). Inhaled Nitric Oxide: State-of-the-Art. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine, vol 1995. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79154-3_26
Download citation
DOI: https://doi.org/10.1007/978-3-642-79154-3_26
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-58256-4
Online ISBN: 978-3-642-79154-3
eBook Packages: Springer Book Archive